Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence

NCT03512249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

831

Enrollment

NETWORK

Sponsor class

Conditions

Tuberculosis, Pulmonary

Interventions

BIOLOGICAL: H56:IC31
BIOLOGICAL: Placebo

Sponsor

International AIDS Vaccine Initiative

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]